Connection
Arnon Haran to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Arnon Haran has written about Hematopoietic Stem Cell Transplantation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.217 |
|
|
|
-
Frisch A, Ganzel C, Ofran Y, Krayem B, Haran A, Vainstein V, Aumann S, Even-Zohar NG, Nachmias B. Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission. Eur J Haematol. 2025 Apr; 114(4):641-649.
Score: 0.144
-
Nachmias B, Haran A, Yisraeli Salman M, Stein EM. Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insights. Br J Haematol. 2025 Oct; 207(4):1192-1212.
Score: 0.038
-
Gross Even Zohar N, Oanunu U, Gross Even-Zohar N, Aumann S, Vainstein V, Gural A, Gatt ME, Haran A, Nachmias B. Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia. Acta Haematol. 2025; 148(6):664-674.
Score: 0.036